Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy
BACKGROUND: Serum tumour necrosis factor-alpha (TNF-α) levels correlate negatively with hepatitis C virus (HCV) antiviral response.
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2014/367131 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832563928171806720 |
|---|---|
| author | Curtis Cooper Stephen Shafran Susan Greenbloom Robert Enns John Farley Nir Hilzenrat Kurt Williams Magdy Elkashab Nabil Abadir Manuela Neuman |
| author_facet | Curtis Cooper Stephen Shafran Susan Greenbloom Robert Enns John Farley Nir Hilzenrat Kurt Williams Magdy Elkashab Nabil Abadir Manuela Neuman |
| author_sort | Curtis Cooper |
| collection | DOAJ |
| description | BACKGROUND: Serum tumour necrosis factor-alpha (TNF-α) levels correlate negatively with hepatitis C virus (HCV) antiviral response. |
| format | Article |
| id | doaj-art-86d716f953a848e887b86bf777a0cec6 |
| institution | Kabale University |
| issn | 2291-2789 2291-2797 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology and Hepatology |
| spelling | doaj-art-86d716f953a848e887b86bf777a0cec62025-02-03T01:12:15ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972014-01-01281354010.1155/2014/367131Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin TherapyCurtis Cooper0Stephen Shafran1Susan Greenbloom2Robert Enns3John Farley4Nir Hilzenrat5Kurt Williams6Magdy Elkashab7Nabil Abadir8Manuela Neuman9University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, CanadaUniversity of Alberta, Edmonton, Alberta, CanadaToronto Digestive Disease Associates, Toronto, Ontario, CanadaSt Paul’s Hospital, University of British Columbia, CanadaPrivate Practice, Vancouver, British Columbia, CanadaJewish General Hospital and McGill University, Montreal, Quebec, CanadaRoyal University Hospital, Saskatoon, Saskatchewan, CanadaPrivate practice, Toronto, Ontario, CanadaMerck Canada Inc, Kirkland, Quebec, CanadaUniversity of Toronto, Toronto, Ontario, CanadaBACKGROUND: Serum tumour necrosis factor-alpha (TNF-α) levels correlate negatively with hepatitis C virus (HCV) antiviral response.http://dx.doi.org/10.1155/2014/367131 |
| spellingShingle | Curtis Cooper Stephen Shafran Susan Greenbloom Robert Enns John Farley Nir Hilzenrat Kurt Williams Magdy Elkashab Nabil Abadir Manuela Neuman Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy Canadian Journal of Gastroenterology and Hepatology |
| title | Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy |
| title_full | Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy |
| title_fullStr | Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy |
| title_full_unstemmed | Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy |
| title_short | Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy |
| title_sort | single dose infliximab in hepatitis c genotype 1 treatmentnaive patients with high serum levels of tumour necrosis factor alpha does not influence the efficacy of pegylated interferon alpha 2b ribavirin therapy |
| url | http://dx.doi.org/10.1155/2014/367131 |
| work_keys_str_mv | AT curtiscooper singledoseinfliximabinhepatitiscgenotype1treatmentnaivepatientswithhighserumlevelsoftumournecrosisfactoralphadoesnotinfluencetheefficacyofpegylatedinterferonalpha2bribavirintherapy AT stephenshafran singledoseinfliximabinhepatitiscgenotype1treatmentnaivepatientswithhighserumlevelsoftumournecrosisfactoralphadoesnotinfluencetheefficacyofpegylatedinterferonalpha2bribavirintherapy AT susangreenbloom singledoseinfliximabinhepatitiscgenotype1treatmentnaivepatientswithhighserumlevelsoftumournecrosisfactoralphadoesnotinfluencetheefficacyofpegylatedinterferonalpha2bribavirintherapy AT robertenns singledoseinfliximabinhepatitiscgenotype1treatmentnaivepatientswithhighserumlevelsoftumournecrosisfactoralphadoesnotinfluencetheefficacyofpegylatedinterferonalpha2bribavirintherapy AT johnfarley singledoseinfliximabinhepatitiscgenotype1treatmentnaivepatientswithhighserumlevelsoftumournecrosisfactoralphadoesnotinfluencetheefficacyofpegylatedinterferonalpha2bribavirintherapy AT nirhilzenrat singledoseinfliximabinhepatitiscgenotype1treatmentnaivepatientswithhighserumlevelsoftumournecrosisfactoralphadoesnotinfluencetheefficacyofpegylatedinterferonalpha2bribavirintherapy AT kurtwilliams singledoseinfliximabinhepatitiscgenotype1treatmentnaivepatientswithhighserumlevelsoftumournecrosisfactoralphadoesnotinfluencetheefficacyofpegylatedinterferonalpha2bribavirintherapy AT magdyelkashab singledoseinfliximabinhepatitiscgenotype1treatmentnaivepatientswithhighserumlevelsoftumournecrosisfactoralphadoesnotinfluencetheefficacyofpegylatedinterferonalpha2bribavirintherapy AT nabilabadir singledoseinfliximabinhepatitiscgenotype1treatmentnaivepatientswithhighserumlevelsoftumournecrosisfactoralphadoesnotinfluencetheefficacyofpegylatedinterferonalpha2bribavirintherapy AT manuelaneuman singledoseinfliximabinhepatitiscgenotype1treatmentnaivepatientswithhighserumlevelsoftumournecrosisfactoralphadoesnotinfluencetheefficacyofpegylatedinterferonalpha2bribavirintherapy |